Perseon Engages SunTrust Robinson Humphrey to Evaluate Strategic Options
March 02 2015 - 9:15AM
Perseon Corporation (Nasdaq:PRSN) (Perseon or the Company), a
leading provider of medical systems that utilize heat therapy to
treat cancer, today announced that its Board of Directors is
exploring strategic options to enhance shareholder value. The Board
has retained SunTrust Robinson Humphrey as its financial advisor to
assist in this important initiative for the Company.
"We have taken definitive steps over the past few months that
have positioned the company for strong future growth, and therefore
we believe we have many options available to us to maximize the
value of our leading microwave ablation platform," said Clint
Carnell, Perseon's Chief Executive Officer. "Our Board believes now
is an appropriate time to engage a leading, well-respected
financial advisor to provide pragmatic, objective advice to assist
us in assessing our strategic options. We remain deeply committed
to our customers and peers in Life Sciences and look forward to
continuing to educate the market on the clinical and economic
benefits of our leading technology."
There can be no assurance that the Board's process will result
in any specific action, and the Company does not intend to disclose
further developments unless and until its Board approves a specific
action or otherwise concludes the review of strategic options.
About Perseon
Perseon Corporation, formerly BSD Medical Corporation, is a life
sciences company that develops, manufactures, markets and services
groundbreaking medical systems to treat cancer using heat therapy.
Perseon's MicroThermX® microwave ablation system employs
precision-guided microwave energy to ablate (destroy) soft tissue.
The Company has developed extensive intellectual property and
distributes its products in the United States, Europe and Asia.
Forward-Looking Statements
Statements contained in this press release that are not
historical facts, including statements relating to our pursuit of
potential strategic opportunities, our potential growth and
maximizing the value of our microwave ablation platform are
forward-looking statements, as defined in the Private Securities
Litigation Reform Act of 1995. All forward-looking statements are
subject to risks and uncertainties, including the risk that for a
variety of reasons we may not be able to execute on our strategic
plans, and other risks and uncertainties detailed in the Company's
filings with the Securities and Exchange Commission. These
forward-looking statements speak only as of the date on which such
statements are made, and the Company undertakes no obligation to
update such statements to reflect events or circumstances arising
after such date, except as required by law.
CONTACT: Tricia Ross
Financial Profiles
310-622-8226
tross@finprofiles.com